icddr, b is an international health research organisation located in Dhaka, Bangladesh. Dedicated to saving lives through research and treatment, icddr, b addresses some of the most critical health concerns facing the world today, ranging from improving neonatal survival to HIV/AIDS.

During the past decade, ICDDR,B conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 4 clinical trials were completed, i.e. on average, 4.4% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 3 clinical trials were completed. i.e. 7.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICDDR,B" #1 sponsor was "International Centre for Diarrhoeal Disease Research, Bangladesh" with 80 trials, followed by "PATH" with 9 trials sponsored, "Centers for Disease Control and Prevention" with 8 trials sponsored, "University of Virginia" with 6 trials sponsored and "The Hospital for Sick Children" with 6 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICDDR,B" #1 collaborator was "International Centre for Diarrhoeal Disease Research, Bangladesh" with 50 trials as a collaborator, "Bill and Melinda Gates Foundation" with 14 trials as a collaborator, "University of Virginia" with 6 trials as a collaborator, "Aga Khan University" with 5 trials as a collaborator and "Johns Hopkins Bloomberg School of Public Health" with 5 trials as a collaborator. Other collaborators include 204 different institutions and companies that were collaborators in the rest 146 trials.

According to Clinical.Site data, the most researched conditions in "ICDDR,B" are "Cholera" (18 trials), "Diarrhea" (15 trials), "Poliomyelitis" (10 trials), "Malnutrition" (7 trials) and "Pregnancy" (5 trials). Many other conditions were trialed in "ICDDR,B" in a lesser frequency.

Most popular intervention types in "ICDDR,B" are "Biological" (37 trials), "Drug" (34 trials), "Other" (28 trials), "Dietary Supplement" (26 trials) and "Behavioral" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Azithromycin" (6 trials), "Shanchol" (5 trials), "Ciprofloxacin" (2 trials) and "IPV" (2 trials). Other intervention names were less common.

The vast majority of trials in "ICDDR,B" are 126 trials for "All" genders, 21 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 35 active trials in "ICDDR,B". 7 are not yet recruiting, 18 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 102 completed trials in ICDDR,B, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in ICDDR,B, 12 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 57 trials that are defined as “Not Applicable".